allowing alternative treatment centers to acquire and use in manufacturing hemp-derived cannabidiol (CBD) isolate.

Introduced

In Committee

Floor

Crossed Over

Passed

Enacted

Overview Bill text History 5 Sponsors 1

Apr 7, 2021 · House

Inexpedient to Legislate: MA VV 04/07/2021 HJ 5 P. 32

Apr 7, 2021 · House

Reconsider (Rep. Osborne): MF VV 04/07/2021 HJ 5 P. 50

Mar 2, 2021 · House

Committee Report: Inexpedient to Legislate (Vote 20-0; CC) HC 18 P. 15

Feb 23, 2021 · House

Public Hearing: 02/23/2021 09:45 am Members of the public may attend using the following link:To join the webinar: https://www.zoom.us/j/95885653389 / Executive session on pending legislation may be held throughout the day (time permitting) from the time the committee is initially convened.

Jan 4, 2021 · House

Introduced (in recess of) 01/06/2021 and referred to Health, Human Services and Elderly Affairs HJ 2 P. 34

PASSAGE PROBABILITY

3.8% Unlikely

Why this number

Stage base In Committee — base rate 27%, measured from NH's completed sessions
Momentum -4 30/100 from the pace of recorded action
Time since last action -22 2012 days quiet
Sponsor influence +4 85/100

A transparent scoring model over stage, momentum, recency, sponsorship and recorded votes — not a trained predictor. Treat it as a way to rank attention, not as a forecast.